In an attempt to help address the opioid epidemic in the U.S., the ADA announced a new policy. The new policy has three main components:
- The ADA supports mandatory continuing education in prescribing opioids and other controlled substances.
- The ADA supports statutory limits on opioid dosage and duration of no more than seven days for the treatment of acute pain, consistent with the CDC evidence-based guidelines.
- The ADA supports dentists registering with and using prescription drug monitoring programs to promote the appropriate use of opioids and deter misuse and abuse.1
The purpose of the new policy is to help educate dentists on how to recognize behavioral issues among patients and teach them about pain management. The policy limits duration of opioid prescriptions to seven days to help mitigate addiction issues. The third component of the policy is meant to help dentists track patients with potential opioid problems.
Let’s talk spore testing!
Talk with one of our experts to get your questions answered and see how we can help you solve your spore testing pain points.